Integer Holdings Corporation announced that its executive leadership team will participate in three major investor conferences in March 2026: Raymond James 47th Annual Institutional Investors Conference (March 3), Oppenheimer 36th Annual Healthcare MedTech & Services Conference (March 17), and KeyBanc Capital Markets Healthcare Forum (March 18). Live webcasts and replays will be available on the company's investor relations website.

Irenic Capital Management sold 1,047,583 shares of Surgery Partners (SGRY) in Q4 2025, reducing its stake to just 0.09% of assets. The stock has declined 39.7% over the past year, underperforming the S&P 500 by 51.61 percentage points. While the company's operations remain solid with 6.6% revenue growth, concerns center on high leverage with net debt to EBITDA at 4.2x-4.6x in a higher rate environment.

Irenic Capital Management LP significantly reduced its Papa John's International position by approximately 70%, selling 748,592 shares in Q4 and retaining only 325,108 shares valued at $12.5 million. The stake now represents just 0.8% of the fund's AUM, dropping out of its top five holdings. Papa John's stock has underperformed the market, declining 30.7% over the past year while the S&P 500 gained 16.4%, amid struggling North American same-store sales.

Integer Holdings (ITGR) stock rose over 2% on Friday following strong Q4 2025 earnings results and multiple analyst upgrades. Benchmark upgraded the stock to buy with a $95 price target, while Wells Fargo and Truist Securities raised their price targets. The company reported 5% year-over-year sales growth to $472 million and a 22% increase in non-GAAP net income to $62 million.

A securities class action lawsuit has been filed against Integer Holdings Corporation for allegedly making materially false and misleading statements about its competitive position in the electrophysiology manufacturing market and overstating the growth potential of its EP devices. Investors who purchased Integer common stock between July 25, 2024 and October 22, 2025 may be entitled to compensation. The deadline to serve as lead plaintiff is February 9, 2026.

A class action lawsuit has been filed against Integer Holdings Corporation (NYSE:ITGR) for securities fraud, alleging the company overstated demand for its electrophysiology devices while actual sales fell sharply. The stock dropped 32% on October 23, 2025, after Integer lowered its 2025 guidance and admitted to slower-than-forecasted adoption of two EP devices. Investors have until February 9, 2026, to join the lawsuit.

A class action lawsuit has been filed against Integer Holdings Corporation (ITGR) for allegedly overstating its competitive position in the EP manufacturing market and mischaracterizing EP devices as growth drivers while experiencing sustained sales deterioration. Investors who purchased shares between July 25, 2024 and October 22, 2025 can apply to be lead plaintiff by February 9, 2026.

A securities class action lawsuit has been filed against Integer Holdings Corporation for allegedly making materially false and misleading statements about its competitive position in the electrophysiology manufacturing market and overstating growth prospects. Investors who purchased ITGR stock between July 25, 2024 and October 22, 2025 may be eligible for compensation. The deadline to serve as lead plaintiff is February 9, 2026.

A securities class action lawsuit has been filed against Integer Holdings Corporation alleging the company made false statements about its competitive position in the electrophysiology manufacturing market and overstated growth prospects for its cardio & vascular segment devices. Investors who suffered losses between July 25, 2024 and October 22, 2025 can join the lawsuit with a February 9, 2026 deadline to request lead plaintiff status.

A class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) alleging that the company made materially false and misleading statements about its competitive position in the EP device market and overstated growth prospects. The lawsuit covers investors who purchased Integer securities between July 25, 2024 and October 22, 2025. Investors have until February 9, 2026 to request lead plaintiff status.

The Gross Law Firm has filed a securities class action lawsuit against Integer Holdings Corporation (ITGR) on behalf of shareholders who purchased shares between July 25, 2024 and October 22, 2025. The complaint alleges that Integer issued materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market, overstated customer demand visibility, and mischaracterized electrophysiology devices as a long-term growth driver. The deadline to register as a shareholder plaintiff is February 9, 2026.

The Gross Law Firm has filed securities fraud class action lawsuits against agilon health, inc. (AGL), Integer Holdings Corporation (ITGR), and CoreWeave, Inc. (CRWV). The complaints allege that defendants issued materially false and misleading statements regarding financial guidance, overstated positive impacts from strategic actions, and failed to disclose material information. Shareholders who purchased shares during specified class periods are encouraged to register before the respective deadlines to participate in potential recoveries.